Serum levels of cell adhesion molecules in patients with neuromyelitis optica spectrum disorder
Serum levels of cell adhesion molecules in patients with neuromyelitis optica spectrum disorder
About this item
Full title
Author / Creator
Publisher
Bognor Regis: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Bognor Regis: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Objectives
Blood–brain barrier (BBB) disruption is a critical pathological process involved in neuromyelitis optica spectrum disorder (NMOSD). Here, we characterized the profile of five cell adhesion molecules in patients with NMOSD.
Methods
We measured levels of cell adhesion molecules, including ICAM‐1, ICAM‐2, VCAM‐1, PECAM‐1, and NCAM‐...
Alternative Titles
Full title
Serum levels of cell adhesion molecules in patients with neuromyelitis optica spectrum disorder
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_08e19c57b4634873ab260d54fa5da7c8
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_08e19c57b4634873ab260d54fa5da7c8
Other Identifiers
ISSN
2328-9503
E-ISSN
2328-9503
DOI
10.1002/acn3.51167
